鉴定与结直肠腺瘤向癌进展相关致癌途径的关键基因。
Identification of key genes for carcinogenic pathways associated with colorectal adenoma-to-carcinoma progression.
作者信息
Sillars-Hardebol Anke H, Carvalho Beatriz, de Wit Meike, Postma Cindy, Delis-van Diemen Pien M, Mongera Sandra, Ylstra Bauke, van de Wiel Mark A, Meijer Gerrit A, Fijneman Remond J A
机构信息
Department of Pathology (Tumor Profiling Unit), VU University Medical Center, De Boelelaan 1117, 1081HV, Amsterdam, The Netherlands.
出版信息
Tumour Biol. 2010 Apr;31(2):89-96. doi: 10.1007/s13277-009-0012-1. Epub 2010 Jan 21.
Colorectal adenomas form a biologically and clinically distinct intermediate stage in development of colorectal cancer (CRC) from normal colon epithelium. Only 5% of adenomas progress into adenocarcinomas, indicating that malignant transformation requires other biological alterations than those involved in adenoma formation. The present study aimed to explore which cancer-related biological processes are affected during colorectal adenoma-to-carcinoma progression and to identify key genes within these pathways that can serve as tumor markers for malignant transformation. The activity of 12 cancer-related biological processes was compared between 37 colorectal adenomas and 31 adenocarcinomas, using the pathway analysis tool Gene Set Enrichment Analysis. Expression of six gene sets was significantly increased in CRCs compared to adenomas, representing chromosomal instability, proliferation, differentiation, invasion, stroma activation, and angiogenesis. In addition, 18 key genes were identified for these processes based on their significantly increased expression levels. For AURKA and PDGFRB, increased mRNA expression levels were verified at the protein level by immunohistochemical analysis of a series of adenomas and CRCs. This study revealed cancer-related biological processes whose activities are increased during malignant transformation and identified key genes which may be used as tumor markers to improve molecular characterization of colorectal tumors.
结直肠腺瘤在从正常结肠上皮发展为结直肠癌(CRC)的过程中形成了一个生物学和临床上截然不同的中间阶段。只有5%的腺瘤会进展为腺癌,这表明恶性转化需要除腺瘤形成过程中涉及的那些生物学改变之外的其他改变。本研究旨在探索在结直肠腺瘤向癌进展过程中哪些与癌症相关的生物学过程受到影响,并确定这些途径中的关键基因,这些基因可作为恶性转化的肿瘤标志物。使用通路分析工具基因集富集分析(Gene Set Enrichment Analysis)比较了37个结直肠腺瘤和31个腺癌中12个与癌症相关的生物学过程的活性。与腺瘤相比,6个基因集的表达在CRC中显著增加,代表染色体不稳定、增殖、分化、侵袭、基质激活和血管生成。此外,基于其显著增加的表达水平,为这些过程鉴定了18个关键基因。对于极光激酶A(AURKA)和血小板衍生生长因子受体β(PDGFRB),通过对一系列腺瘤和CRC进行免疫组织化学分析,在蛋白质水平验证了mRNA表达水平的增加。本研究揭示了在恶性转化过程中其活性增加的与癌症相关的生物学过程,并鉴定了可作为肿瘤标志物以改善结直肠肿瘤分子特征的关键基因。
相似文献
Gastroenterology. 2002-10
Scand J Gastroenterol. 2012-11
引用本文的文献
iScience. 2024-3-6
bioRxiv. 2023-12-5
Cancer Res Commun. 2023-11-13
Rheumatology (Oxford). 2023-7-5
Oncol Lett. 2022-5-16
Histol Histopathol. 2022-2
本文引用的文献
Oncogene. 2006-12-4
Adv Immunol. 2006
Nat Rev Cancer. 2006-2